T43.1X2D Poisoning by monoamine-oxidase-inhibitor antidepressants, intentional self-harm, subsequent encounter

Name of the Condition

• Poisoning by monoamine-oxidase-inhibitor antidepressants, intentional self-harm, subsequent encounter
• Technical term: T43.1X2D

Summary

This code describes intentional self-harm poisoning by monoamine-oxidase-inhibitor (MAOI) antidepressants during a subsequent encounter. MAOIs are a class of medications used to treat depression and other mental health conditions. The code applies when clinical documentation specifies intentional overdose of an MAOI and the encounter is not the initial one for this event.

Causes

Intentional self-harm poisoning occurs when a patient deliberately takes more than the prescribed dose of an MAOI with the intent to harm themselves. This may involve taking the medication in excess or combining it with other substances. Adverse effects can also occur due to the body's reaction to the drug, though poisoning implies a higher-than-intended dose.

Risk Factors

• History of mental health conditions that increase self-harm risk.
• Concurrent use of medications that interact with MAOIs (e.g., certain antidepressants, pain relievers).
• Poor medication adherence or lack of understanding of dosing instructions.
• Pre-existing conditions like cardiovascular disease or liver impairment that heighten adverse effect risk.

Symptoms

Symptoms may include:

• Altered mental status, confusion, or agitation.
• Hypertensive crisis (severe headache, rapid heart rate, chest pain).
• Nausea, vomiting, or abdominal pain.
• Seizures or loss of consciousness.

Diagnosis

Diagnosis relies on clinical documentation confirming intentional self-harm and subsequent encounter status. Healthcare providers assess symptoms, medication history, and intent. Laboratory tests may be used to detect drug levels, though clinical judgment is primary.

Treatment Options

Treatment focuses on stabilizing the patient, managing symptoms, and addressing underlying mental health needs. This may include activated charcoal, supportive care, and psychiatric evaluation. Long-term care often involves therapy and medication management.

Prognosis and Follow-Up

Prognosis depends on the severity of the poisoning and timely intervention. Follow-up care is critical to address mental health concerns and prevent recurrence. Regular monitoring and support are typically recommended.

Complications

Complications can include organ damage, prolonged mental health issues, or recurrence of self-harm. Severe cases may result in permanent disability or death.

Lifestyle & Prevention

Prevention involves secure medication storage, adherence to prescribed doses, and access to mental health support. Education on risks and early intervention for mental health concerns can reduce self-harm incidents.

When to Seek Professional Help

Seek immediate help if symptoms of poisoning occur, such as altered mental status, severe headache, or loss of consciousness. Ongoing professional support is essential for mental health management.

Tips for Medical Coders

Document intent (intentional self-harm) and encounter type (subsequent) clearly. Ensure the code aligns with clinical notes specifying MAOI involvement and self-harm. Verify no other codes better describe the scenario.